South Korean health officials on Wednesday approved Pfizer’s COVID-19 vaccine for children aged 5 to 11, expanding the country’s immunization program in the face of a massive omicron outbreak.
Repeated COVID-19 testing of millions of Beijing residents is starting to test the patience of some as the city clamps down on the virus ahead of the coming Winter Olympics.